GlobalData predicts huge diabetes market growth, names Novo Nordisk drugs as drivers
The type 2 diabetes treatment market will triple in size over ten years, according to the analysis firm’s estimations.
by christopher due karlsson, translated by daniel pedersen
The market for type 2 diabetes treatments is already worth billions of dollars for some of the world’s largest pharmaceutical firms, including Novo Nordisk – and analysis firm GlobalData predicts that the market will continue to grow even bigger in the future.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
